Kymera’s stock rises after derma investigation expands; Ligand buys Apeiron

Plus, news about AEON Biopharma, Moderna and Mitsubishi Tanabe:

Sanofi expands dermatology trials: Kymera Therapeutics said that expanding the Phase …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Wearable, non-invasive device can measure activity in human cervical nerves in clinical settings

A research team led by UC San Diego has, for the first time, shown that a wearable, non-invasive device can measure activity in human cervical

July 29, 2024

MorphoSys AG Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update – Biotech Investments

EQS-News: MorphoSys AG / Key word(s): Annual Report MorphoSys AG Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update 13.03.2024 /

March 14, 2024

Red Light Holland Psilocybin Microdosing Capsules Aimed to Be Distributed in Emerging Markets Pass Four Month Stability Testing by C-CREST Laboratories in Montreal, Canada | Psychedelic Invest

Red Light Holland’s natural psilocybin microdosing capsules developed from psilocybin truffles grown in the Company’s farm in The Netherlands, have received the results of four

November 13, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.